SYNTH MR Stock Swiss Exchange
Equities
SE0005454865
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- SEK | - |
Sales 2024 * | 112M 10.31M | Sales 2025 * | 145M 13.36M | Capitalization | 1.15B 106M |
---|---|---|---|---|---|
Net income 2024 * | 22M 2.03M | Net income 2025 * | 39M 3.59M | EV / Sales 2024 * | 10.1 x |
Net cash position 2024 * | 28.42M 2.62M | Net cash position 2025 * | 44.3M 4.08M | EV / Sales 2025 * | 7.65 x |
P/E ratio 2024 * |
50.5
x | P/E ratio 2025 * |
29.2
x | Employees | - |
Yield 2024 * |
0.72% | Yield 2025 * |
1.08% | Free-Float | 42.6% |
Managers | Title | Age | Since |
---|---|---|---|
Ulrik Harrysson
CEO | Chief Executive Officer | 55 | 19-08-31 |
Founder | 51 | 07-02-15 | |
Johanna Norén
DFI | Director of Finance/CFO | 50 | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 12-12-31 | |
Director/Board Member | 60 | - | |
Founder | 51 | 07-02-15 |
1st Jan change | Capi. | |
---|---|---|
+4.63% | 32.15B | |
+17.45% | 7.41B | |
+20.94% | 3.85B | |
-17.01% | 3.13B | |
-22.16% | 1.25B | |
-31.01% | 1.17B | |
+4.40% | 926M | |
-34.81% | 911M | |
-25.64% | 842M |